InsidersTradesSigma
Explore the detailed record of transactions filed by LeBel Carl, Directeur du Développement. Insider active across 1 companies, notably Frequency Therapeutics, Inc.. Aggregated, 4 reports have been logged. Total volume traded: €10k. The latest transaction was filed on 18 February 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
4 of 4 declarations
Carl LeBel serves as the Chief Development Officer at Frequency Therapeutics, Inc. He is responsible for leading the company's strategic development initiatives. With his expertise, he plays a key role in driving innovation and business growth.